'Cytokines therapy' gaining momentum for treating Alopecia

By Michelle Yeomans

- Last updated on GMT

'Cytokines therapy' gaining momentum for treating Alopecia

Related tags Effectiveness Cosmetics Medicine

Korean based ‘AesMed’ has developed a hair loss treatment solution based on ‘Cytokines therapy’ to control hair cell activation.

The company’s ‘Systematic Growth factors-57 (SGF-57)’, is said to be effective due to cytokine and growth factors of KGF, SCF, IGF-1, VEGF, bFGF and rh-SOD; blended well to the consistency of optimized density for regulating hair loss and improving hair growth.

Cytokine is proven by many medical journals to differentiate and proliferate hair cells, and control hair growth cycle​,” the company states.

Since the launch of what AesMed claims was the 'world’s first hair loss treatment by using growth factors', back in 2008, SGF-57 has since been used in ten university hospitals equipped with hair loss treatment centers, dermatology and cosmetic surgery clinics for alopecia sufferers in Korea.

"In more than 600,000 cases for performing alopecia treatment, SGF-57 has been proven to show its outstanding effectiveness and safety without any side effects until now​," say reps.

Recognised by peer reviewed journals..

Alopecia is one of the most common conditions to affect and even bother young people, though people of any age can be affected.

Compared to current treatments such as Finasteride and Dutasteride, Aesmed claims SGF-57 is becoming a much more effective treatment for men and women, "free from side effects widely arisen in the three treatments."

The ingredient has been covered by journals like 'The Journal of Dermatology​', classified at a SCI level for a clinical study of SGF-57 for treating female alopecia.

“This clinical study is worth of notice for the world’s first paper in the SCI-leveled journal which verifies clinical effectiveness for alopecia treatment by cosmetics rather than medicines​,” adds AesMed CEO, Joe.

About AesMed

AesMed specializes in the design and development of cosmetics and medical devices in South Korea, manufacturing and providing beauty products to departments of dermatology and cosmetic surgery, and university hospitals since 2007.

In association with universities, clinical centers and institutions, the company has developed verified and proven cosmeceutical products including SGF-57 for alopecia treatment based on its own advanced technologies.

Related topics Formulation & Science Hair Care

Related news

Show more

Related products

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Related suppliers

Follow us

Products

View more

Webinars

Podcast

Beauty 4.0 Podcast